Komori
Ricksoft (4429) · FactAdvanced

Research and Development Activities in the Tool Solutions Business

First written in FY2021-Q1. 21 of 22 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2027-H1.

22entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2021-Q2 – FY2027-H12020: 220202021: 420212022: 420222023: 420232024: 420242025: 220252026: 22026
Same theme, other companies
Recognition and Disclosure of R&D ExpensesA theme 73 companies write about · 0 as a headwind · 21 as a tailwind

8 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 73 companies compared. The sentences above are computed from all 73.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1AdvancedAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥152.096 million, all of which arose in the Solutions business.」

    Discloses total R&D expenses of ¥152.096 million for FY2027-H1.
  2. FY2026AdvancedAnnual report

    「Total R&D expenses incurred by the group during the current consolidated fiscal year were ¥270.757 million.」

    Discloses total R&D expenses of ¥270.757 million for the fiscal year ended February 2026, up from ¥261.659 million in the previous fiscal year.
  3. FY2026-H1AdvancedAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥133.302 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥133.302 million for FY2026-H1.
  4. FY2025AdvancedAnnual report

    「Total R&D expenses incurred by the group during the current consolidated fiscal year were ¥261.659 million.」

    Discloses total R&D expenses of ¥261.659 million for the fiscal year ended February 2025, up from ¥184.526 million in the previous fiscal year.
  5. FY2025-H1AdvancedAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥127.377 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥127.377 million for the current interim consolidated accounting period.
  6. FY2025-Q1AdvancedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥57.810 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥57.810 million for FY2025-Q1.
  7. FY2024AdvancedAnnual report

    「Total R&D expenses incurred by the group during the current consolidated fiscal year were ¥184.526 million.」

    Discloses total R&D expenses of ¥184.526 million for the fiscal year ended February 2024, up from ¥168.406 million in the previous fiscal year.
  8. FY2024-Q3AdvancedAnnual report

    「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥136.405 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥136.405 million for the cumulative third quarter of the 22nd fiscal year.
  9. FY2024-Q2AdvancedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥83.545 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥83.545 million for the cumulative second quarter of the 22nd fiscal year.
  10. FY2024-Q1AdvancedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥38.784 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥38.784 million for FY2024-Q1.
  11. FY2023AdvancedAnnual report

    「Total R&D expenses incurred by the group during the current consolidated fiscal year were ¥168.406 million.」

    Discloses total R&D expenses of ¥168.406 million for the fiscal year ended February 2023, up from ¥139.745 million in the previous fiscal year.
  12. FY2023-Q3AdvancedAnnual report

    「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥135.133 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥135.133 million for the cumulative third quarter of the consolidated fiscal year.
  13. FY2023-Q2AdvancedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥89.179 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥89.179 million for the cumulative second quarter of the 21st fiscal year.
  14. FY2023-Q1AdvancedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥42.906 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥42.906 million for FY2023-Q1.
  15. FY2022AdvancedAnnual report

    「Total R&D expenses incurred by the group during the current consolidated fiscal year were ¥139.745 million.」

    Discloses total R&D expenses of ¥139.745 million for the fiscal year ended February 2022, up from ¥82.545 million in the previous fiscal year.
  16. FY2022-Q3AdvancedAnnual report

    「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥97.495 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥97.495 million for the FY2022-Q3 cumulative period.
  17. FY2022-Q2AdvancedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥59.089 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥59.089 million for the FY2022-Q2 cumulative period.
  18. FY2022-Q1AdvancedAnnual report

    「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥26.282 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥26.282 million for FY2022-Q1, up from ¥21.259 million in the first quarter of the previous fiscal year.
  19. FY2021AdvancedAnnual report

    「Total R&D expenses incurred by the group during the current consolidated fiscal year were ¥82.545 million.」

    Discloses total R&D expenses of ¥82.545 million for the fiscal year ended February 2021.
  20. FY2021-Q3AdvancedAnnual report

    「Total R&D expenses for the cumulative third quarter of the current consolidated fiscal year were ¥64.158 million, all of which arose in the Tool Solutions business.」

    Discloses R&D expenses of ¥64.158 million for the cumulative third quarter of the consolidated fiscal year, up from ¥43.474 million in the previous cumulative second quarter in both the period covered and the amount.
  21. FY2021-Q2AdvancedAnnual report

    「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥43.474 million, all of which arose in the Tool Solutions business.」

    Discloses R&D expenses of ¥43.474 million for the cumulative second quarter, up from ¥21.259 million in the previous first quarter in both the period covered and the amount.
  22. FY2021-Q1First statedAnnual report

    「Total R&D expenses for the first quarter of the current consolidated fiscal year were ¥21.259 million, all of which arose in the Tool Solutions business.」

    Discloses total R&D expenses of ¥21.259 million for the cumulative first quarter of the current consolidated fiscal year.
Moved together

"Net Sales and Earnings Performance for the First Quarter of the Fiscal Year Ending May 2019" moved the same way as this thread, in the same document, in 21 of its 22 moves.

21191413137★123456
  1. ★This thread
  2. 1Net Sales and Earnings Performance for the First Quarter of the Fiscal Year Ending May 201921×
  3. 2Increase in Total Assets and Net Assets at November 2020 Month-End19×
  4. 3Consulting, Platform Development and Cloud Services Centered on Atlassian Products14×
  5. 4Disclosure of Revenue from Contracts with Customers by Timing of Transfer13×
  6. 5Share issuance and capital increase through the exercise of stock acquisition rights13×
  7. 6Enhancing Technological Capabilities and Expanding Customer Segments through M&A and Capital and Business Alliances7×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Ricksoft yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and Development Activities in the Tool Solutions Business | Ricksoft Co.,Ltd. (4429) | Komori